Opendata, web and dolomites

EPICAN SIGNED

Inhibiting tumor cell plasticity by targeting the epigenome in breast cancer

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 EPICAN project word cloud

Explore the words cloud of the EPICAN project. It provides you a very rough idea of what is the project "EPICAN" about.

pik3ca    transformation    genetic    demonstrated    regulate    anti    resistance    outcomes    tumor    overarching    unknown    prevent    mechanisms    heterogeneous    regulation    pi3k    histological    combined    signaling    regulators    mostly    e545k    interactions    microenvironment    clinical    presenting    giving    therapy    cell    oncogenic    kinase    validate    lineage    participate    epigenetic    disease    committed    mammary    situ    multipotent    block    reactivates    70    temporal    molecular    classified    single    diversity    mediated    epigenome    tumors    reduce    subgroups    outgrowth    breast    hypothesize    malignancy    fate    cancers    driver    cells    inhibitors    mice    multipotency    spatio    conditional    pik3cah1047r    reprograms    alterations    akt    hyperactive    activation    ill    downstream    synergize    expression    phosphoinositide    inhibition    heterogeneity    plasticity    underlying    mutations    epithelial    mutant    demonstrates    hurdle    cancer    activating    oncogene    kinases    progenitors    h1047r    transgenic    tracing    paramount   

Project "EPICAN" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAT BASEL 

Organization address
address: PETERSPLATZ 1
city: BASEL
postcode: 4051
website: www.unibas.ch

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Switzerland [CH]
 Total cost 191˙149 €
 EC max contribution 191˙149 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2020
 Duration (year-month-day) from 2020-05-01   to  2022-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAT BASEL CH (BASEL) coordinator 191˙149.00

Map

 Project objective

Breast cancer is a heterogeneous disease which is classified into different histological and molecular subgroups presenting different clinical outcomes. Also, the diversity of genetic/epigenetic alterations in cancer cells and their interactions with the microenvironment enhance cell plasticity and result in intra-tumor heterogeneity. While tumor heterogeneity is a major hurdle to anti-cancer therapy, its underlying molecular mechanisms remain ill-defined. The Phosphoinositide 3-kinase (PI3K) pathway, which is hyperactive in more than 70% of breast cancers mostly due to oncogenic activating mutations (PIK3CA-E545K & PIK3CA-H1047R), is a major driver of cell transformation. Using spatio-temporal conditional expression of the mutant PIK3CAH1047R combined with in situ lineage tracing in transgenic mice, recent studies demonstrated that the PIK3CA-H1047R oncogene reprograms lineage-committed mammary epithelial progenitors into a multipotent state, giving rise to heterogeneous mammary tumors. However, the mechanisms by which the PIK3CA-H1047R oncogene reactivates multipotency in breast cancer remain unknown. An increasing number of studies demonstrates that epigenetic regulators participate downstream of PI3K/AKT kinases to regulate the epigenome and contribute to tumor malignancy. Given the importance of epigenetic regulation for cell fate, I hypothesize that the effects of PIK3CA-H1047R signaling on tumor cell plasticity are mediated by epigenetic regulators. Because single inhibition of the PI3K pathway often results in resistance, it is of paramount interest to identify new targets whose inhibition can synergize with PI3K inhibitors to block tumor outgrowth, reduce tumor heterogeneity and prevent resistance. The overarching goal of this proposal is to identify epigenetic regulators downstream of oncogenic activation of the PI3K pathway leading to tumor cell plasticity, and to validate them as new targets in breast cancer.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EPICAN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EPICAN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

Photonic Radar (2019)

Implementation of Long Reach Hybrid Photonic Radar System and convergence over FSO and PON Networks

Read More  

CORRELATION (2020)

Characterization and prediction of service-level traffic for future sliced mobile network

Read More  

STMICRO (2020)

Space-time visualization of microelectronic chip operation with femtosecond electron microscopy

Read More